149 related articles for article (PubMed ID: 28223245)
21. Chitosan-Modified Cationic Amino Acid Nanoparticles as a Novel Oral Delivery System for Insulin.
Abbad S; Zhang Z; Waddad AY; Munyendo WL; Lv H; Zhou J
J Biomed Nanotechnol; 2015 Mar; 11(3):486-99. PubMed ID: 26307831
[TBL] [Abstract][Full Text] [Related]
22. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
[TBL] [Abstract][Full Text] [Related]
23. Can aggregation of insulin govern its fate in the intestine? Implications for oral delivery of the drug.
Smirnova E; Safenkova I; Stein-Margolina V; Shubin V; Gurvits B
Int J Pharm; 2014 Aug; 471(1-2):65-8. PubMed ID: 24853465
[TBL] [Abstract][Full Text] [Related]
24. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of cytoprotective effect of amino acids on local toxicity caused by sodium laurate, a drug absorption enhancer, in intestinal epithelium.
Endo Y; Hanada K; Miyake M; Ogawara K; Higaki K; Kimura T
J Pharm Sci; 2002 Mar; 91(3):730-43. PubMed ID: 11920758
[TBL] [Abstract][Full Text] [Related]
26. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
[TBL] [Abstract][Full Text] [Related]
27. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
Jørgensen JR; Jepsen ML; Nielsen LH; Dufva M; Nielsen HM; Rades T; Boisen A; Müllertz A
Eur J Pharm Biopharm; 2019 Oct; 143():98-105. PubMed ID: 31425857
[TBL] [Abstract][Full Text] [Related]
28. PEPT1-mediated uptake of dipeptides enhances the intestinal absorption of amino acids via transport system b(0,+).
Wenzel U; Meissner B; Döring F; Daniel H
J Cell Physiol; 2001 Feb; 186(2):251-9. PubMed ID: 11169462
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
[TBL] [Abstract][Full Text] [Related]
30. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
31. Oligoarginine-linked polymers as a new class of penetration enhancers.
Sakuma S; Suita M; Masaoka Y; Kataoka M; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Yamashita S
J Control Release; 2010 Dec; 148(2):187-96. PubMed ID: 20800631
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of intestinal absorption of macromolecules by spermine in rats.
Sugita Y; Takao K; Toyama Y; Shirahata A
Amino Acids; 2007 Aug; 33(2):253-60. PubMed ID: 17653818
[TBL] [Abstract][Full Text] [Related]
33. Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers.
Niu Z; Tedesco E; Benetti F; Mabondzo A; Montagner IM; Marigo I; Gonzalez-Touceda D; Tovar S; Diéguez C; Santander-Ortega MJ; Alonso MJ
J Control Release; 2017 Oct; 263():4-17. PubMed ID: 28235590
[TBL] [Abstract][Full Text] [Related]
34. Emulsion-based colloidal nanosystems for oral delivery of doxorubicin: improved intestinal paracellular absorption and alleviated cardiotoxicity.
Kim JE; Yoon IS; Cho HJ; Kim DH; Choi YH; Kim DD
Int J Pharm; 2014 Apr; 464(1-2):117-26. PubMed ID: 24463005
[TBL] [Abstract][Full Text] [Related]
35. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
[TBL] [Abstract][Full Text] [Related]
36. Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin.
Patel LN; Wang J; Kim KJ; Borok Z; Crandall ED; Shen WC
Mol Pharm; 2009; 6(2):492-503. PubMed ID: 19228019
[TBL] [Abstract][Full Text] [Related]
37. Protein Corona Liposomes Achieve Efficient Oral Insulin Delivery by Overcoming Mucus and Epithelial Barriers.
Wang A; Yang T; Fan W; Yang Y; Zhu Q; Guo S; Zhu C; Yuan Y; Zhang T; Gan Y
Adv Healthc Mater; 2019 Jun; 8(12):e1801123. PubMed ID: 30485708
[TBL] [Abstract][Full Text] [Related]
38. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
39. Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography.
Kamei N; Morishita M; Kanayama Y; Hasegawa K; Nishimura M; Hayashinaka E; Wada Y; Watanabe Y; Takayama K
J Control Release; 2010 Aug; 146(1):16-22. PubMed ID: 20457194
[TBL] [Abstract][Full Text] [Related]
40. The transport of cationic amino acids in human airway cells: expression of system y+L activity and transepithelial delivery of NOS inhibitors.
Rotoli BM; Bussolati O; Sala R; Gazzola GC; Dall'Asta V
FASEB J; 2005 May; 19(7):810-2. PubMed ID: 15746185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
